UHS UNIVERSAL HEALTH SERVICES INC
Price Chart
Executive Summary
Universal Health Services reported strong 2025 financial results with 9.7% revenue growth and a 37.3% increase in adjusted EPS to $21.74, driven by volume and pricing improvements across both acute and behavioral health segments. The company also announced a favorable court ruling vacating a $500 million punitive damages verdict, though it maintains an $18 million reserve for the matter. Management provided optimistic 2026 guidance, forecasting 7.1% revenue growth and 8.5% adjusted EPS growth.
Key Financial Metrics
Actionable Insight
The combination of strong operational performance, optimistic guidance, and resolution of a major litigation overhang presents a compelling investment case. The stock may re-rate higher on improved sentiment, though investors should monitor Medicaid reimbursement risks mentioned in the forward-looking statements.
Key Facts
- 2025 revenue grew 9.7% to $17.365 billion; adjusted EPS increased 30.9% to $21.74
- 2026 guidance calls for $18.417-$18.789 billion revenue (7.1% midpoint growth) and $22.64-$24.52 EPS (8.5% midpoint growth)
- Nevada court vacated $500 million punitive damages verdict, though $18 million legal reserve remains
- Behavioral health same-facility revenue grew 7.7%, acute care grew 8.5% in 2025
- Company repurchased $899.3 million of stock in 2025 with $1.425 billion remaining authorization
Financial Impact
2025 revenue $17.365 billion (+9.7% YoY), adjusted EPS $21.74 (+30.9% YoY); 2026 revenue guidance $18.6 billion midpoint (+7.1% YoY), EPS guidance $23.58 midpoint (+8.5% YoY)
Segment Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Acute Care | $9.9B | +8.5% |
| Behavioral Health | $7.4B | +8.0% |
Risk Factors
- Potential reinstatement of punitive damages on appeal (though capped at $14 million under Nevada law)
- Legislative changes limiting Medicaid enrollment and provider fees could impact future revenues
- Interest rate increases have adversely impacted free cash flow
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-073545 |
| Document: uhs-20260225.htm | 0001193125-26-073545 |
| Document: 0001193125-26-073545-index-headers.html | 0001193125-26-073545 |
| Document: 0001193125-26-073545-index.html | 0001193125-26-073545 |
| Document: 0001193125-26-073545.txt | 0001193125-26-073545 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 21, 2026
24d ago
|
8-K
| $162.28 $146.00 | ▼ −10.03% | ▼ −11.88% | $146.42 (−9.77%) |
|
Apr 24, 2026
7w ago
|
8-K
| $173.78 $168.27 | ▼ −3.17% | ▼ −4.08% | $146.42 (−15.74%) |
|
Apr 9, 2026
9w ago
|
DEFA14A
| $187.57 $178.58 | ▼ −4.79% | ▼ −7.98% | $146.42 (−21.94%) |
|
Feb 26, 2026
15w ago
|
8-K
| $203.26 $196.81 | ▼ −3.17% | ▼ −2.05% | $146.42 (−27.96%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access